Food and Drug Administration Oversight

Members of the Food and Drug Administration’s Science Board testified about the report, “The FDA Commission at Risk,”… read more

Members of the Food and Drug Administration’s Science Board testified about the report, “The FDA Commission at Risk,” that they helped write. Topics included the FDA’s inability to fulfill its mission because of its eroding scientific base, its negative approach to oversight, and significant budget cuts over the last 35 years. It was recommended that the FDA budget be doubled over the next two years and that the number of personnel be increased by at least 50 percent.

Commissioner Andrew Von Eschenbach testified about the FDA’s response to the report. 

Gail Cassell was chair of the FDA Science Board subcommittee that wrote the report. close

Javascript must be enabled in order to access C-SPAN videos.

*The transcript for this program was compiled from uncorrected Closed Captioning.

People in this video

More People

Hosting Organization

More information about

Food and Drug Administration Oversight

200 Views
Program ID:
203822-1
Category:
House Committee
Format:
House Committee
Location:
Washington, District of Columbia, United States
First Aired:
Jan 29, 2008
Last Aired:
Feb 22, 2008

Airing Details

  • Jan 29, 2008 | 10:01am EST | C-SPAN 3
  • Jan 30, 2008 | 12:43am EST | C-SPAN 1
  • Feb 01, 2008 | 12:04pm EST | C-SPAN 3
  • Feb 03, 2008 | 10:32am EST | C-SPAN 1
  • Feb 22, 2008 | 1:56pm EST | C-SPAN 2
Purchase a DVD or Download

Food and Drug Administration Oversight

  • DVD
    Length:
    04:56:29
    Price:
    $29.95
    Add to Cart
  • MP4 video - Standard
    Request Download
  • MP4 video - Low
    Request Download
  • MP3 audio
    Length:
    04:56:29
    Price:
    $0.99
    Add to Cart

Clips from This Video